B. Winters

发表

Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype

Thomas Lengauer, Yardena Peres, Rolf Kaiser, 2008, Antiviral therapy.

A Synthetic HIV-1 Subtype C Backbone Generates Comparable PR and RT Resistance Profiles to a Subtype B Backbone in a Recombinant Virus Assay

D. Nauwelaers, L. Stuyver, K. Van Baelen, 2011, PloS one.

Reporter gene expression from LTR-circles as tool to identify HIV-1 integrase inhibitors.

R. Clayton, M. Van Loock, B. Malcolm, 2013, Journal of virological methods.

Virological Response to Darunavir/Ritonavir-Based Regimens in Antiretroviral-Experienced Patients (PREDIZISTA Study)

D. Breilh, D. Neau, H. Fleury, 2008, Antiviral therapy.

Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients.

L. Stuyver, J. Aerssens, I. Vandenbroucke, 2012, Virology.

A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences

T. F. Rinke de Wit, L. Stuyver, W. Stevens, 2010, AIDS research and therapy.

Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.

L. Bacheler, J. Villacian, E. Van Craenenbroeck, 2009, Journal of virological methods.

Determination of Clinically Relevant Cutoffs for HIV-1 Phenotypic Resistance Estimates Through a Combined Analysis of Clinical Trial and Cohort Data

S. Hammer, B. Gazzard, L. Bacheler, 2008, Journal of acquired immune deficiency syndromes.

A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes.

L. Stuyver, K. Van Baelen, E. Rondelez, 2009, Journal of virological methods.

CXCR4-Using HIV Type 1 Variants Are More Commonly Found in Peripheral Blood Mononuclear Cell DNA Than in Plasma RNA

L. Stuyver, I. Vandenbroucke, L. Vandekerckhove, 2009, Journal of acquired immune deficiency syndromes.

The Influence of the M184V Mutation in HIV-1 Reverse Transcriptase on the Virological Outcome of Highly Active Antiretroviral Therapy Regimens with Or without Didanosine

B. Gazzard, N. Graham, A. Pozniak, 2005, Antiviral Therapy.

Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals.

L. Bacheler, T. Pattery, P. Sista, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.